Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis. | Front Med (Lausanne) | 2022 | 35755064 | PubTator, text mining | PubMed |
| Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity. | J Cell Physiol | 2022 | 35754396 | PubTator, text mining | PubMed |
| Household size, T regulatory cell development, and early allergic disease: a birth cohort study. | Pediatr Allergy Immunol | 2022 | 35754137 | PubTator, text mining | PubMed |
| Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid. | Comput Biol Med | 2022 | 35751199 | PubTator, text mining | PubMed |
| Development and Validation of a Hypoxia-related Prognostic Model for Ovarian Cancer. | Recent Pat Anticancer Drug Discov | 2022 | 35747984 | PubTator, text mining | PubMed |
| Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V2) Therapy. | Curr Oncol | 2022 | 35735437 | PubTator, text mining | PubMed |
| A BIRC5High COD1Low Cancer Tissue Phenotype Indicates Poorer Prognosis of Metastatic Breast Cancer Patients. | Cancer Inform | 2022 | 35734521 | PubTator, text mining | PubMed |
| Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19. | Front Pediatr | 2022 | 35733812 | PubTator, text mining | PubMed |
Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment. | Front Oncol | 2022 | 35719968 | PubTator, text mining | PubMed |
| Biological Characterization and Clinical Value of OAS Gene Family in Pancreatic Cancer. | Front Oncol | 2022 | 35719943 | PubTator, text mining | PubMed |
| Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods. | Sci Rep | 2022 | 35705632 | PubTator, text mining | PubMed |
| Successful ABO-incompatible kidney transplantation and SARS-CoV-2-specific immune monitoring in a patient recovered from coronavirus infection. | Kidney Res Clin Pract | 2022 | 35698754 | PubTator, text mining | PubMed |
| Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine. | Cureus | 2022 | 35698717 | PubTator, text mining | PubMed |
| The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants. | Immunity | 2022 | 35690062 | PubTator, text mining | PubMed |
| RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells. | Cell Rep Med | 2022 | 35688159 | PubTator, text mining | PubMed |
| Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. | Comput Struct Biotechnol J | 2022 | 35685361 | PubTator, text mining | PubMed |
| [Classic hairy cell leukemia with MAP2K1 mutation: a case report]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35680604 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer. | Clin Cancer Res | 2022 | 35675036 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection. | Cell Rep | 2022 | 35662411 | PubTator, text mining | PubMed |
| Master of mimicry: Rare primary cutaneous anaplastic large cell lymphoma presenting as fungating parotid tumor-case report and review. | Int J Surg Case Rep | 2022 | 35658304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=47